Key result
Direct thrombin inhibitors offer an effective alternative to heparin for anticoagulation in various thromboembolic disorders, though they lack an antidote or readily available clinical monitoring.
Population
Patients who suffer from heparin-induced thrombocytopaenia, thromboembolic disorders, and acute coronary…
Comparison
Direct thrombin inhibitors vs Heparin and currently available anticoagulants
Design
Review
Authors
Loading...
May warrant use in heparin-intolerant patients; leaves open need for reversal agents and standardized monitoring.
Direct thrombin inhibitors provide an effective alternative to heparin for anticoagulation in HIT, thromboembolic disorders, and ACS, despite lacking an antidote and routine monitoring.
Kam et al. (2005) conducted a review in Thrombosis, heparin-induced thrombocytopaenia, thromboembolic disorders, and acute coronary syndromes. Direct thrombin inhibitors vs. Heparin was evaluated. Direct thrombin inhibitors offer an effective alternative to heparin for anticoagulation in various thromboembolic disorders, though they lack an antidote or readily available clinical monitoring.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: